IL159789A0 - Active ingredient combination for pharmacological therapy of nicotine dependence - Google Patents

Active ingredient combination for pharmacological therapy of nicotine dependence

Info

Publication number
IL159789A0
IL159789A0 IL15978902A IL15978902A IL159789A0 IL 159789 A0 IL159789 A0 IL 159789A0 IL 15978902 A IL15978902 A IL 15978902A IL 15978902 A IL15978902 A IL 15978902A IL 159789 A0 IL159789 A0 IL 159789A0
Authority
IL
Israel
Prior art keywords
active ingredient
ingredient combination
nicotine dependence
pharmacological therapy
pharmacological
Prior art date
Application number
IL15978902A
Other languages
English (en)
Original Assignee
Hf Arzneimittelforsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hf Arzneimittelforsch Gmbh filed Critical Hf Arzneimittelforsch Gmbh
Publication of IL159789A0 publication Critical patent/IL159789A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Addiction (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL15978902A 2001-07-12 2002-07-05 Active ingredient combination for pharmacological therapy of nicotine dependence IL159789A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10134038A DE10134038A1 (de) 2001-07-12 2001-07-12 Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit
PCT/EP2002/007477 WO2003007966A1 (de) 2001-07-12 2002-07-05 Wirkstoff-kombination zur medikamentösen therapie der nikotinabhängigkeit

Publications (1)

Publication Number Publication Date
IL159789A0 true IL159789A0 (en) 2004-06-20

Family

ID=7691630

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15978902A IL159789A0 (en) 2001-07-12 2002-07-05 Active ingredient combination for pharmacological therapy of nicotine dependence
IL159789A IL159789A (en) 2001-07-12 2004-01-08 Combination of active ingredient for medical treatment of nicotine dependence

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL159789A IL159789A (en) 2001-07-12 2004-01-08 Combination of active ingredient for medical treatment of nicotine dependence

Country Status (28)

Country Link
US (1) US20040167145A1 (es)
EP (1) EP1404341B1 (es)
JP (1) JP2005502633A (es)
KR (1) KR20040013143A (es)
CN (1) CN1527712A (es)
AR (1) AR034767A1 (es)
AT (1) ATE340576T1 (es)
AU (1) AU2002354856B2 (es)
BR (1) BR0211323A (es)
CA (1) CA2452432C (es)
CZ (1) CZ301204B6 (es)
DE (2) DE10134038A1 (es)
DK (1) DK1404341T3 (es)
EA (1) EA007628B1 (es)
ES (1) ES2274064T3 (es)
HK (1) HK1063159A1 (es)
HU (1) HUP0401013A3 (es)
IL (2) IL159789A0 (es)
MX (1) MXPA04000344A (es)
MY (1) MY131858A (es)
NO (1) NO20040119L (es)
NZ (1) NZ530512A (es)
PL (1) PL367779A1 (es)
PT (1) PT1404341E (es)
SK (1) SK112004A3 (es)
UA (1) UA79752C2 (es)
WO (1) WO2003007966A1 (es)
ZA (1) ZA200400305B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10338544B4 (de) * 2003-08-19 2017-08-31 Janssen Pharmaceutica N.V. Buccale Formulierungen des Galanthamins und deren Anwendungen
DE10354893B4 (de) * 2003-11-24 2011-03-10 Hf Arzneimittelforschung Gmbh Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen
CL2008003507A1 (es) 2007-11-26 2009-11-27 Neuroderm Ltd Composicion farmaceutica que comprende nicotina y un inhibidor de la desensibilizacion del receptor de acetilcolina nicotinico (nachr) opipramol; kit farmaceutico; dispositivo medico; y uso para tratar una enfermedad o trastorno del sistema nervioso central o periferico.
DE102007058504A1 (de) * 2007-12-05 2009-07-09 Acino Ag Transdermales therapeutisches System mit einem Gehalt an einem Modulator für nikotinische Acetylcholinrezeptoren (nAChR)

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US4031894A (en) * 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
DE3315272C2 (de) * 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
US4573995A (en) * 1984-10-09 1986-03-04 Alza Corporation Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
DE3843239C1 (es) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
DE4010079A1 (de) * 1990-03-29 1991-10-02 Lohmann Therapie Syst Lts Pharmazeutische formulierung zur behandlung des alkoholismus
US5519017A (en) * 1990-03-29 1996-05-21 Lts Lohmann Therapie-Systeme Gmbh + Co. Kg Pharmaceutic formulation for the treatment of alcoholism
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
DE4301782C1 (de) * 1993-01-23 1994-08-25 Lohmann Therapie Syst Lts Verwendung von Galanthamin zur Behandlung der Nicotinabhängigkeit
BR9509406A (pt) * 1994-10-21 1998-11-03 Waldheim Pharmazeutica Ges M B Processo para a preparação de 4a,5,9,10,11,12,-hedaxidro-6h-benzofuro(3a,3,2,-ef) [2] benzazepina
DE19509663A1 (de) * 1995-03-17 1996-09-19 Lohmann Therapie Syst Lts Verfahren zur Isolierung von Galanthamin
GB9514821D0 (en) * 1995-07-19 1995-09-20 Sod Conseils Rech Applic Galanthamine derivatives
WO1997018781A1 (en) * 1995-11-20 1997-05-29 University Of Miami Method of treating nicotine dependence
WO1997033581A1 (en) * 1996-03-13 1997-09-18 Yale University Smoking cessation treatments using naltrexone and related compounds
AT403803B (de) * 1996-04-19 1998-05-25 Sanochemia Ltd Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
US5965567A (en) * 1997-07-15 1999-10-12 Albany Medical College Method for treating nicotine addiction
CA2358062C (en) * 1998-12-24 2006-12-19 Janssen Pharmaceutica N.V. Controlled release galantamine composition
DE19906978B4 (de) * 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit
DE19906979B4 (de) * 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit
US6465479B1 (en) * 1999-08-13 2002-10-15 Southern Research Institute Pyridomorphinans and use thereof
US6670356B2 (en) * 1999-12-10 2003-12-30 Bonnie Davis Analogs of galanthamine and lycoramine as modulators of nicotinic receptors
DE10129265A1 (de) * 2001-06-18 2003-01-02 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie

Also Published As

Publication number Publication date
ZA200400305B (en) 2004-05-24
BR0211323A (pt) 2004-11-30
HK1063159A1 (en) 2004-12-17
US20040167145A1 (en) 2004-08-26
DE10134038A1 (de) 2003-02-06
EP1404341B1 (de) 2006-09-27
CN1527712A (zh) 2004-09-08
AU2002354856B2 (en) 2007-05-31
EP1404341A1 (de) 2004-04-07
WO2003007966A1 (de) 2003-01-30
KR20040013143A (ko) 2004-02-11
IL159789A (en) 2008-07-08
PT1404341E (pt) 2007-01-31
DK1404341T3 (da) 2007-02-05
SK112004A3 (en) 2004-06-08
HUP0401013A3 (en) 2011-03-28
JP2005502633A (ja) 2005-01-27
HUP0401013A2 (hu) 2004-08-30
EA007628B1 (ru) 2006-12-29
MY131858A (en) 2007-09-28
EA200400116A1 (ru) 2004-08-26
CA2452432A1 (en) 2003-01-30
CZ200419A3 (cs) 2004-05-12
PL367779A1 (en) 2005-03-07
CA2452432C (en) 2009-09-01
DE50208267D1 (de) 2006-11-09
ES2274064T3 (es) 2007-05-16
MXPA04000344A (es) 2004-05-04
CZ301204B6 (cs) 2009-12-09
NZ530512A (en) 2007-09-28
UA79752C2 (en) 2007-07-25
NO20040119L (no) 2004-01-30
ATE340576T1 (de) 2006-10-15
AR034767A1 (es) 2004-03-17

Similar Documents

Publication Publication Date Title
EP1425277B8 (en) Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
IL161940A0 (en) Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
EP1337249A4 (en) COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF PHARMACOLOGICALLY ACTIVE COMPOUNDS
EP1416884A4 (en) DISTRIBUTION OF AGENTS WITH THERAPEUTIC PROPERTIES
IL196301A0 (en) Medicament for the treatment of hapatitis c
EP1420797A4 (en) DERMAL THERAPY USING PHOSPHATE DERIVATIVES OF ELECTRONIC TRANSFER AGENTS
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL159345A0 (en) Active ingredient combination for pharmacological addictive substances or intoxicant therapy
HUP0303311A3 (en) Highly flexible transdermal therapeutic system having nicotine as active substance
AU9473501A (en) Stabilization of solid drug formulations
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
HUP0204448A3 (en) Trnasdermal therapeutic system for the delivery of lerisetron
GB0107751D0 (en) Pharmaceutically active compounds
GB0105893D0 (en) Pharmaceutically active compounds
GB0106631D0 (en) Pharmaceutically active compounds
IL159789A0 (en) Active ingredient combination for pharmacological therapy of nicotine dependence
AU2002231283A1 (en) Use of p38 inhibitors for the treatment of smoke inhalation
HUP0201287A3 (en) Preventive or therapeutic drugs for various eosinphilia-related diseases containing quinazoline derivative chymase inhibitors as the active ingredient
AU2002354856A1 (en) Active substance combination for medicamentous therapy of nicotine dependency
AU2002351798A1 (en) Methods and dosage forms for improving the bioavailability of therapeutic agents
EP1451308A4 (en) THERAPEUTIC USE OF AZIRIDINO COMPOUNDS
GB0024517D0 (en) Use of medicaments
AU6106801A (en) Trans-clitoral administration of therapy
AU2002350212A8 (en) Pharmaceutically active compounds and methods of use thereof

Legal Events

Date Code Title Description
KB Patent renewed